XML 75 R64.htm IDEA: XBRL DOCUMENT v3.10.0.1
Commitments and Contingencies - Additional Information (Details)
$ in Millions
1 Months Ended 2 Months Ended 3 Months Ended
May 31, 2018
Patent
May 31, 2017
Patent
Dec. 31, 2016
USD ($)
Mar. 31, 2016
USD ($)
May 31, 2018
Patent
Jun. 30, 2016
USD ($)
Jun. 30, 2018
USD ($)
Feb. 28, 2018
Pending_Claim
Dec. 31, 2017
USD ($)
Loss Contingencies [Line Items]                  
Damages awarded     $ 2,540            
Motion invalidated past damages, amount     $ 2,540            
Damages awarded but dismissed       $ 200          
Litigation accrual             $ 0   $ 0
Number of pending claims with motions to dismiss | Pending_Claim               2  
Merck '499 and '712 patents                  
Loss Contingencies [Line Items]                  
Damages awarded but dismissed, value           $ 200      
Amneal Pharmaceuticals, LLC V.S. Gilead Sciences, Inc                  
Loss Contingencies [Line Items]                  
Number of patents allegedly infringed | Patent   2              
Aurobindo Pharma USA Inc V.S. Gilead Sciences, Inc                  
Loss Contingencies [Line Items]                  
Number of patents allegedly infringed | Patent         2        
Strides Pharma, Inc V.S. Gilead Sciences, Inc - Emtricitabine Patent                  
Loss Contingencies [Line Items]                  
Number of patents allegedly infringed | Patent 2                
Strides Pharma, Inc V.S. Gilead Sciences, Inc - Emtricitabine And Tenofovir Patent                  
Loss Contingencies [Line Items]                  
Number of patents allegedly infringed | Patent         4